Fifty410 vs Brello Health: Three-Month Tirzepatide Pricing Compared

Last reviewed: September 5, 2026 Last updated: September 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Fifty410 charges $399, $499, or $549 upfront depending on dose tier for a three-month supply of compounded tirzepatide, shipped immediately. Brello Health charges $499 and rebills every 11 weeks. Both require full prepayment; neither publishes dose-specific pricing beyond tier labels. PlexusDx charges $269/month on a three-month plan with recurring monthly billing and flat pricing at every dose. Over 12 months Fifty410's starter tier costs $1,596 (prepaid quarterly), Brello costs $2,359 if billed strictly every 11 weeks or $1,996 if interpreted as quarterly, and PlexusDx costs $3,228. Fifty410 and Brello deliver lower annualized costs in exchange for upfront payment; PlexusDx spreads the expense monthly and guarantees the same rate regardless of dose.

At-a-glance comparison

Three-month tirzepatide pricing and billing structures

Fifty410: dose-tiered prepayment

Fifty410 offers three tirzepatide tiers—starter, mid, and high dose—each prepaid for a full three-month supply and shipped upfront. Pricing captured September 4, 2026:

• Starter dose: $399 for three months (prepaid per-month equivalent $133/month, our calculation)
• Mid dose: $499 for three months (prepaid per-month equivalent $166/month, our calculation)
• High dose: $549 for three months (prepaid per-month equivalent $183/month, our calculation)

All figures include consult, medication, and shipping. Because the full supply ships upfront, refund options are limited once the package leaves the pharmacy. Fifty410 does not require a membership or recurring subscription; you pay only if a clinician prescribes the medication.

Annualized, the starter tier costs $1,596 (four cycles × $399), the mid tier $1,996, and the high tier $2,196.

Brello Health: 11-week rebilling cycle

Brello Health charges $499 for an 11-week supply of tirzepatide and rebills every 11 weeks. The service advertises this as a three-month plan with a prepaid equivalent of $166.33/month (captured September 4, 2026), but the 11-week cycle is shorter than a calendar quarter. If billed strictly every 11 weeks, a year comprises 4.727 cycles, yielding an annualized cost of approximately $2,359 (our calculation: $499 × 4.727 = $2,358.77, effective monthly $196.56). If interpreted as true quarterly billing (four cycles per year), the annual cost is $1,996.

Brello does not publish dose-specific tiers; the $499 rate applies regardless of dose. The plan requires a three-month minimum commitment and rebills automatically. Consult, medication, and shipping are included; no membership fee is charged. Current evidence does not document whether the 11-week interval is contractual or whether Brello adjusts to quarterly intervals in practice. We recommend confirming the exact billing cadence at enrollment.

PlexusDx: recurring monthly billing on a three-month commitment

PlexusDx charges $269/month for tirzepatide injection on a three-month plan, billed monthly. Over three months the total is $807; over 12 months, $3,228. The same rate applies at every dose—2.5 mg through 15 mg—so patients do not face a price increase when titrating. The plan carries no membership fee, no upfront lump sum, and no separate visit or shipping charges. Patients may cancel anytime; the three-month commitment establishes the per-month rate but does not lock funds upfront.

PlexusDx also offers a month-to-month option at $289/month ($3,468 annually) and a six-month plan at $249/month ($2,988 annually).

12-month cost comparison across billing models

The table below normalizes each option to a 12-month window. All prepaid per-month equivalents are our calculations.

Fifty410's starter and mid tiers deliver the lowest 12-month costs when prepayment is feasible. Brello's annualized cost depends on whether the 11-week cycle is enforced or whether the service treats each cycle as a calendar quarter; confirm the exact interval before enrolling. PlexusDx charges more per month but spreads payments and holds pricing flat across all doses.

Decision factors: prepayment, dose pricing, and billing transparency

Prepayment vs. recurring monthly billing

Fifty410 requires the full three-month payment upfront and ships the entire supply immediately. This structure lowers the annualized cost but requires liquidity and limits recourse if you decide to stop treatment mid-cycle. Brello also prepays each cycle but rebills automatically, so you do not manually renew. PlexusDx bills monthly; you pay $269 each month rather than $807 or more at once, which can ease budgeting but raises the 12-month total.

Dose-tier pricing

Fifty410 charges more as dose increases: $399 for starter, $499 for mid, $549 for high. If you titrate from 2.5 mg to 10 mg over several months, you will move into a higher-priced tier and prepay the new amount for the next cycle. Brello and PlexusDx hold pricing constant regardless of dose, so titration does not trigger a cost increase.

Billing-cycle clarity

Brello's "every 11 weeks" language introduces ambiguity. Eleven weeks is approximately 2.5 calendar months; 4.727 such cycles fit into 52 weeks, yielding the $2,359 annualized figure. The advertised $166.33/month equivalent appears to assume four cycles per year (true quarterly billing), which would produce $1,996 annually. Confirm whether Brello adjusts cycle length or adheres strictly to 11-week intervals; the difference is $363 per year.

Review and service reliability

Fifty410 claims a 4.8-star Trustpilot rating across 5,891 reviews (provider page, captured September 4, 2026). PlexusDx holds a verified 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher (captured September 4, 2026). Brello Health maintains a Trustpilot profile, but star rating and review volume were not captured in the current evidence set. High ratings at Fifty410 suggest consistent fulfillment and support; PlexusDx's verified record demonstrates transparency and accountability.

Choose Fifty410 if…

• You can prepay $399–$549 every three months and prefer receiving the full supply upfront.
• You are confident in your dose tier and do not anticipate frequent titration.
• Minimizing annualized cost is the primary goal and you accept limited flexibility once the medication ships.

Choose Brello Health if…

• You want automatic rebilling without manual renewals and can prepay $499 per cycle.
• Flat pricing across all doses matters more than the lowest possible monthly equivalent.
• You confirm at enrollment that the 11-week billing interval matches your treatment cadence and budget cycle.

Choose PlexusDx if…

• You prefer predictable monthly bills over lump-sum prepayment.
• Dose flexibility is important—you want the same $269 rate whether you take 2.5 mg or 15 mg.
• Transparency matters: one price covers provider visit, prescription, medication, and shipping, with no surprise fees and the freedom to cancel anytime.
• You value a verified Trustpilot record and direct accountability from a service that applies the same evidence standards to its own offerings and competitors.

Methodology and freshness

Pricing, plan terms, and review data for Fifty410 and Brello Health were captured September 4, 2026, from provider websites and Trustpilot profiles. PlexusDx pricing was verified September 5, 2026. All 12-month cost projections are our calculations, derived by multiplying per-cycle charges by the number of cycles per year. Brello's 11-week billing cycle produces 4.727 cycles annually (52 weeks ÷ 11); the quarterly interpretation assumes exactly four cycles. We treat Fifty410's provider-claimed 4.8-star Trustpilot rating as stated on their page; PlexusDx's 4.2-star rating is independently verified. Brello's Trustpilot profile was confirmed to exist, but rating and volume were not captured. All prepaid per-month equivalents are labeled as such; no discount offers or coupon rates are published. Readers should confirm billing intervals, dose-tier definitions, refund policies, and cancellation procedures directly with each provider before enrollment.

Frequently Asked Questions

Does Fifty410 charge more when I increase my tirzepatide dose?

Yes. Fifty410 offers three dose tiers—starter ($399 per three months), mid ($499), and high ($549). Moving to a higher dose requires prepaying the new tier amount for your next three-month cycle.

How often does Brello Health rebill for tirzepatide?

Brello states it rebills every 11 weeks. This is shorter than a calendar quarter and produces 4.727 cycles per year, leading to an annualized cost of approximately $2,359. Confirm the exact interval and whether Brello adjusts cycle length at enrollment.

Can I cancel a PlexusDx three-month plan before three months are up?

Yes. The three-month plan sets the monthly rate ($269 vs. $289 month-to-month) but does not lock your funds upfront. You may cancel anytime and will not be billed for months you do not use.

Do any of these services charge a membership fee for tirzepatide?

No. Fifty410, Brello Health, and PlexusDx all include consult, medication, and shipping in the advertised price with no separate membership or subscription fee.

Which service has the lowest 12-month tirzepatide cost?

Fifty410's starter tier ($1,596 annually) is the lowest if you prepay and remain at the starter dose. Brello costs $1,996 (quarterly interpretation) or $2,359 (11-week cycle), and PlexusDx costs $3,228 on the three-month plan with monthly billing.

Sources

• PlexusDx tirzepatide injection product page and pricing (accessed September 5, 2026)
• Fifty410 provider website, tirzepatide plans and terms (captured September 4, 2026)
• Brello Health provider website, tirzepatide plans and billing details (captured September 4, 2026)
• Trustpilot profiles for Fifty410, Brello Health, and PlexusDx (captured September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.